• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

antibodies

multiple locks with one unlocked
Biotech

Pfizer shares prostate cancer data after leak, inks Alloy deal

Researchers said the combo improved outcomes and has a manageable safety profile, according to the abstract, which was penned by Pfizer's AI tool.
Gabrielle Masson Feb 11, 2025 1:07pm
Heidelberg Germany

Daiichi gins up antibody research collab with German institute

Jan 14, 2025 3:44pm
An artists impression of natural killer cells which look like fluffy pink orbs descending upon and attacking a purple vas

Innate antibody pits NK cells against lymphoma in animal models

Nov 15, 2024 2:00pm
antibody cancer cell blood cancer

Dotmatics debuts antibody engineering R&D software platform

Oct 22, 2024 2:06pm
3D rendering of SARS-CoV-2 virus particles

COVID antibodies shut down variants, earn $35M BARDA bucks

Oct 9, 2024 2:00pm
Experienced laboratory scientist analyzing a botulism sample from a canned food can

GigaGen garners up to $135M BARDA bucks to beat botulism

Oct 3, 2024 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings